Optimization of M4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology

被引:22
作者
Melancon, Bruce J. [1 ,2 ]
Wood, Michael R. [1 ,3 ]
Noetzel, Meredith J. [1 ,2 ]
Nance, Kellie D. [1 ]
Engelberg, Eileen M. [1 ]
Han, Changho [1 ]
Lamsal, Atin [1 ]
Chang, Sichen [1 ]
Cho, Hyekyung P. [1 ,2 ]
Byers, Frank W. [1 ]
Bubser, Michael [1 ]
Jones, Carrie K. [1 ,2 ,5 ]
Niswender, Colleen M. [1 ,2 ,5 ]
Wood, Michael W. [4 ]
Engers, Darren W. [1 ,2 ]
Wu, Dedong [6 ]
Brandon, Nicholas J. [4 ]
Duggan, Mark E. [4 ]
Conn, Jeffrey [1 ,2 ,5 ]
Bridges, Thomas M. [1 ,2 ]
Lindsley, Craig W. [1 ,2 ,3 ]
机构
[1] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA
[4] AstraZeneca, Neurosci Innovat Med & Early Dev, Waltham, MA 02451 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA
[6] AstraZeneca, Pharmaceut Sci, 35 Gatehouse Dr, Waltham, MA 02451 USA
关键词
M-4; Muscarinic acetylcholine receptor; Positive allosteric modulator (PAM); Non-human primate (NHP); Structure-Activity Relationship (SAR); MUSCARINIC ACETYLCHOLINE-RECEPTOR; SCHIZOPHRENIA; POTENTIATORS; CHALLENGES; SERIES; CORE;
D O I
10.1016/j.bmcl.2017.04.043
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This letter describes the further chemical optimization of the 5-amino-thieno(2,3-c]pyridazine series (VU0467154/VU0467485) of M-4 positive allosteric modulators (PAMs), developed via iterative parallel synthesis, culminating in the discovery of the non-human primate (NHP) in vivo tool compound, VU0476406 (8p). VU0476406 is an important in vivo tool compound to enable translation of pharmacodynamics from rodent to NHP, and while data related to a Parkinson's disease model has been reported with 8p, this is the first disclosure of the optimization and discovery of VU0476406, as well as detailed pharmacology and DMPK properties. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2296 / 2301
页数:6
相关论文
共 19 条
[1]   Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats [J].
Brady, Ashley E. ;
Jones, Carrie K. ;
Bridges, Thomas M. ;
Kennedy, J. Phillip ;
Thompson, Analisa D. ;
Heiman, Justin U. ;
Breininger, Micah L. ;
Gentry, Patrick R. ;
Yin, Huiyong ;
Jadhav, Satyawan B. ;
Shirey, Jana K. ;
Conn, P. Jeffrey ;
Lindsley, Craig W. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (03) :941-953
[2]   Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents [J].
Bubser, Michael ;
Bridges, Thomas M. ;
Dencker, Ditte ;
Gould, Robert W. ;
Grannan, Michael ;
Noetzel, Meredith J. ;
Lamsal, Atin ;
Niswender, Colleen M. ;
Daniels, J. Scott ;
Poslusney, Michael S. ;
Melancon, Bruce J. ;
Tarr, James C. ;
Byers, Frank W. ;
Wess, Juergen ;
Duggan, Mark E. ;
Dunlop, John ;
Wood, Michael W. ;
Brandon, Nicholas J. ;
Wood, Michael R. ;
Lindsley, Craig W. ;
Conn, P. Jeffrey ;
Jones, Carrie K. .
ACS CHEMICAL NEUROSCIENCE, 2014, 5 (10) :920-942
[3]   Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100 [J].
Byun, Nellie E. ;
Grannan, Michael ;
Bubser, Michael ;
Barry, Robert L. ;
Thompson, Analisa ;
Rosanelli, John ;
Gowrishankar, Raajaram ;
Kelm, Nathaniel D. ;
Damon, Stephen ;
Bridges, Thomas M. ;
Melancon, Bruce J. ;
Tarr, James C. ;
Brogan, John T. ;
Avison, Malcolm J. ;
Deutch, Ariel Y. ;
Wess, Juergen ;
Wood, Michael R. ;
Lindsley, Craig W. ;
Gore, John C. ;
Conn, P. Jeffrey ;
Jones, Carrie K. .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 (07) :1578-1593
[4]   Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia [J].
Chan, W. Y. ;
McKinzie, D. L. ;
Bose, S. ;
Mitchell, S. N. ;
Witkin, J. M. ;
Thompson, R. C. ;
Christopoulos, A. ;
Lazareno, S. ;
Birdsall, N. J. M. ;
Bymaster, F. P. ;
Felder, C. C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (31) :10978-10983
[5]   Allosteric Antipsychotics: M4 Muscarinic Potentiators as Novel Treatments for Schizophrenia [J].
Farrell, Martilias ;
Roth, Bryan L. .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (04) :851-852
[6]  
Foster DJ, 2016, NEURON, V91, P1224
[7]   Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia [J].
Jones, Carrie K. ;
Byun, Nellie ;
Bubser, Michael .
NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) :16-42
[8]   Synthesis and Structure-Activity Relationships of Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor [J].
Kennedy, J. Phillip ;
Bridges, Thomas M. ;
Gentry, Patrick R. ;
Brogan, John T. ;
Kane, Alexander S. ;
Jones, Carrie K. ;
Brady, Ashley E. ;
Shirey, Jana K. ;
Conn, P. Jeffrey ;
Lindsley, Craig W. .
CHEMMEDCHEM, 2009, 4 (10) :1600-1607
[9]   Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: Development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia [J].
Le, Uyen ;
Melancon, Bruce J. ;
Bridges, Thomas M. ;
Vinson, Paige N. ;
Utley, Thomas J. ;
Lamsal, Atin ;
Rodriguez, Alice L. ;
Venable, Daryl ;
Sheffler, Douglas J. ;
Jones, Carrie K. ;
Blobaum, Anna L. ;
Wood, Michael R. ;
Daniels, J. Scott ;
Conn, P. Jeffrey ;
Niswender, Colleen M. ;
Lindsley, Craig W. ;
Hopkins, Corey R. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) :346-350
[10]   Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties [J].
Leach, Katie ;
Loiacono, Richard E. ;
Felder, Christian C. ;
McKinzie, David L. ;
Mogg, Adrian ;
Shaw, David B. ;
Sexton, Patrick M. ;
Christopoulos, Arthur .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (04) :855-869